oseltamivir has been researched along with Shock, Septic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Gao, J; Li, D; Xia, H; Xiu, M | 1 |
Ala-Kokko, T; Herwald, H; Kaukonen, KM; Lindbom, L; Linko, R; Pettilä, V; Ruokonen, E | 1 |
Chuang, YC; Ku, YH; Yu, WL | 1 |
Bello, S; de Pablo, F; Fandos, S; Figueredo, AL; Minchole, E; Omeñaca, M; Panadero, C; Royo, L; Vengoechea, JJ | 1 |
Boura, P; Mouloudi, E; Sarantopoulos, A; Tselios, K; Tsioka, R | 1 |
Bonastre, J; Guerrero, JE; Martín-Loeches, I; Pozo, JC; Rodríguez, A; Suberviola, B; Torres, A | 1 |
6 other study(ies) available for oseltamivir and Shock, Septic
Article | Year |
---|---|
Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in a Chinese adult: A case report.
Topics: Aged; Anti-Bacterial Agents; Cough; Healthcare-Associated Pneumonia; Humans; Hypokinesia; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Mezlocillin; Oseltamivir; Shock, Septic; Staphylococcal Infections | 2020 |
Heparin-binding protein (HBP) in critically ill patients with influenza A(H1N1) infection.
Topics: Adult; Antimicrobial Cationic Peptides; Antiviral Agents; Blood Proteins; Carrier Proteins; Critical Illness; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Prospective Studies; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Shock, Septic | 2013 |
Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis.
Topics: Aged; Antiviral Agents; Bronchoalveolar Lavage Fluid; Disease Management; Disease Progression; Fatal Outcome; Hemopneumothorax; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Lung; Male; Nasopharynx; Oseltamivir; Radiography; Shock, Septic; Thoracentesis | 2017 |
Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pneumonia; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Seasons; Shock, Septic; Treatment Outcome; Young Adult | 2016 |
Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lupus Erythematosus, Systemic; Middle Aged; Oseltamivir; Radiography, Thoracic; Shock, Septic; Steroids; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2011 |
[Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A (H1N1) in Spain].
Topics: Acute Kidney Injury; Adult; Antiviral Agents; Disease Outbreaks; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Male; Multiple Organ Failure; Oseltamivir; Pneumonia, Viral; Prospective Studies; Renal Replacement Therapy; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Seasons; Shock, Septic; Spain | 2012 |